HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.

Abstract
The present studies were conducted to examine the role of cerebrovascular guanylate cyclase in hypoxic cerebral vasodilatation. In arteries mounted in vitro for measurements of isometric tension, 20 min of hypoxia (bath oxygen partial pressure, approximately 15 Torr) significantly increased cyclic GMP levels from 16 to 32, from 15 to 25 and from 20 to 38 pmol/g in rabbit common carotid, internal carotid and basilar arteries. These increases were blocked either by pretreatment with 3 microM methylene blue, or by removal of the vascular endothelium. Methylene blue also significantly delayed hypoxic relaxation in the basilar and internal carotid arteries, and blocked transient hypoxic vasoconstriction in the common carotid. Together, these in vitro results demonstrate that vascular cytosolic guanylate cyclase participates in an endothelium-dependent manner in the direct effects of hypoxia on cerebral arteries, and that the nature of this participation varies significantly between arteries. When methylene blue (20 mg/kg) was administered in vivo, however, it had no effect on the magnitude of hypoxic cerebral vasodilatation as determined by both local (mass spectrometry) and global (venous outflow) methods of blood flow measurement. This latter finding suggests that: 1) large and small cerebral arteries may differ significantly in terms of either endothelial function or sensitivity to methylene blue; or 2) feedback regulation of other mechanisms of hypoxic cerebral vasodilatation compensate for the effects of guanylate cyclase inhibition. Additional experiments using other inhibitors of cytosolic guanylate cyclase and/or vessels isolated from the cerebral microcirculation will be necessary to distinguish between these possibilities.
AuthorsW J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro, J Seylaz
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 254 Issue 2 Pg. 616-25 (Aug 1990) ISSN: 0022-3565 [Print] United States
PMID2166799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Papaverine
  • Nitroglycerin
  • Cyclic GMP
  • Methylene Blue
Topics
  • Animals
  • Cerebrovascular Circulation (drug effects)
  • Cyclic GMP (metabolism)
  • Drug Interactions
  • Hypoxia (enzymology)
  • Injections, Intravenous
  • Male
  • Methylene Blue (pharmacology)
  • Muscle, Smooth, Vascular (drug effects, enzymology)
  • Nitroglycerin (pharmacology)
  • Papaverine (pharmacology)
  • Rabbits
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: